Showing results (1641-1650 of 4,601) with videos related to
Sort By:
Pageof 461
Chemmedchem|December 8, 2007
Lessons learnt from assembling screening libraries for drug discovery for neglected diseasesRuth Brenk, Alessandro Schipani, Daniel James, et al.Chemmedchem|November 19, 2016
Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6Philip M Cox, Namandjé N BumpusChemmedchem|November 19, 2016
Characterization of a Cell-Penetrating Peptide with Potential Anticancer ActivityAnja Gronewold, Mareike Horn, Ivan Ranđelović, et al.Chemmedchem|February 17, 2010
Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimizationChunquan Sheng, Wenya Wang, Xiaoying Che, et al.Chemmedchem|January 14, 2010
Rational design, synthesis, and potency of N-substituted indoles, pyrroles, and triarylpyrazoles as potential fructose 1,6-bisphosphatase inhibitorsAleksandra Rudnitskaya, Dmitry A Borkin, Ken Huynh, et al.Chemmedchem|January 16, 2010
Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligandsMariangela Agamennone, Lucia Cesari, Daniela Lalli, et al.Chemmedchem|January 21, 2010
Molecular modeling studies on the human neuropeptide S receptor and its antagonistsDiego Dal Ben, Ippolito Antonini, Michela Buccioni, et al.Chemmedchem|March 12, 2010
Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agentsChiara Falciani, Jlenia Brunetti, Chiara Pagliuca, et al.Chemmedchem|November 19, 2009
Discovery of potent vascular endothelial growth factor receptor-2 inhibitorsAthanasios Papakyriakou, Maria E Katsarou, Maria Belimezi, et al.Chemmedchem|January 1, 2010
Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studiesMohammad A Khanfar, Diaa T A Youssef, Khalid A El SayedPageof 461